Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

A prospective study of serum C-reactive protein and colorectal cancer risk in men.

Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Weinstein S, Wood RJ, Virtamo J, Taylor PR, Albanes D, Sinha R.

Cancer Res. 2006 Feb 15;66(4):2483-7.

2.

Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.

Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S; Japan Public Health Center-Based Prospective Study Group.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):690-5.

3.

C-reactive protein levels are not associated with increased risk for colorectal cancer in women.

Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM.

Ann Intern Med. 2005 Mar 15;142(6):425-32.

PMID:
15767620
4.

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.

Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH.

Circulation. 1998 Feb 10;97(5):425-8.

5.

C-reactive protein and colorectal adenomas: Self Defense Forces Health Study.

Otake T, Uezono K, Takahashi R, Fukumoto J, Tabata S, Abe H, Tajima O, Mizoue T, Ohnaka K, Kono S.

Cancer Sci. 2009 Apr;100(4):709-14.

PMID:
19469014
6.

Serum alpha-tocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts.

Longnecker MP, Martin-Moreno JM, Knekt P, Nomura AM, Schober SE, Stähelin HB, Wald NJ, Gey KF, Willett WC.

J Natl Cancer Inst. 1992 Mar 18;84(6):430-5.

PMID:
1531683
7.

C-reactive protein concentrations and subsequent ovarian cancer risk.

McSorley MA, Alberg AJ, Allen DS, Allen NE, Brinton LA, Dorgan JF, Pollak M, Tao Y, Helzlsouer KJ.

Obstet Gynecol. 2007 Apr;109(4):933-41.

PMID:
17400857
8.

Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.

Chiu HM, Lin JT, Chen TH, Lee YC, Chiu YH, Liang JT, Shun CT, Wu MS.

Am J Gastroenterol. 2008 Sep;103(9):2317-25. doi: 10.1111/j.1572-0241.2008.01952.x.

PMID:
18844617
9.

Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study.

Kuijsten A, Hollman PC, Boshuizen HC, Buijsman MN, van 't Veer P, Kok FJ, Arts IC, Bueno-de-Mesquita HB.

Am J Epidemiol. 2008 Mar 15;167(6):734-42. doi: 10.1093/aje/kwm349. Epub 2008 Jan 12.

PMID:
18192676
10.

C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.

Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, Hofman A, Pols HA, Stricker BH.

J Clin Oncol. 2006 Nov 20;24(33):5216-22.

PMID:
17114654
11.

C-reactive protein and colorectal adenoma in the CLUE II cohort.

Tsilidis KK, Erlinger TP, Rifai N, Hoffman S, Hoffman-Bolton J, Helzlsouer KJ, Platz EA.

Cancer Causes Control. 2008 Aug;19(6):559-67. doi: 10.1007/s10552-008-9117-x. Epub 2008 Jan 24.

PMID:
18214695
12.

Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case-control study nested in the Japan Collaborative Cohort Study.

Suzuki K, Ito Y, Wakai K, Kawado M, Hashimoto S, Toyoshima H, Kojima M, Tokudome S, Hayakawa N, Watanabe Y, Tamakoshi K, Suzuki S, Ozasa K, Tamakoshi A; Japan Collaborative Cohort Study Group.

Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1781-7.

13.

Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea.

Chung YW, Han DS, Park YK, Son BK, Paik CH, Lee HL, Jeon YC, Sohn JH.

Dig Liver Dis. 2006 Sep;38(9):668-72. Epub 2006 Jun 21.

PMID:
16790371
14.

C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study.

Helzlsouer KJ, Erlinger TP, Platz EA.

Eur J Cancer. 2006 Apr;42(6):704-7. Epub 2006 Mar 2.

PMID:
16513341
15.

Is C-reactive protein a prognostic factor of colorectal cancer?

Shiu YC, Lin JK, Huang CJ, Jiang JK, Wang LW, Huang HC, Yang SH.

Dis Colon Rectum. 2008 Apr;51(4):443-9. doi: 10.1007/s10350-007-9133-z. Epub 2008 Jan 3.

PMID:
18172726
16.

A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.

Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL.

J Natl Cancer Inst. 2007 Jul 18;99(14):1120-9. Epub 2007 Jul 10.

PMID:
17623801
17.

Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study.

Weinstein SJ, Wright ME, Pietinen P, King I, Tan C, Taylor PR, Virtamo J, Albanes D.

J Natl Cancer Inst. 2005 Mar 2;97(5):396-9.

PMID:
15741576
18.

C-reactive protein and the risk of incident colorectal cancer.

Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ.

JAMA. 2004 Feb 4;291(5):585-90.

PMID:
14762037
19.

[Association between C-reactive protein level and metabolic syndrome and components thereof].

Bao YQ, Jia WP, Chen L, Lu JX, Xiang KS.

Zhonghua Yi Xue Za Zhi. 2006 Aug 15;86(30):2105-9. Chinese.

PMID:
17064612
20.

Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan Public Health Center-based prospective study.

Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S; Japan Public Health Center-based Prospective Study Group.

Cancer Causes Control. 2008 Feb;19(1):67-74. Epub 2007 Oct 18.

PMID:
17943453

Supplemental Content

Support Center